Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Phillip Read

Showing results (51-60 of 82) with videos related to

Pageof 9
Sort By:
The International Journal on Drug Policy|August 24, 2021
Effectiveness of treatment for hepatitis C virus reinfection following direct acting antiviral therapy in the REACH-C cohortJoanne M Carson, Behzad Hajarizadeh, Josh Hanson, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 30, 2022
Low Prior Exposure and Incidence of Hepatitis C in Human Immunodeficiency Virus-Negative Gay and Bisexual Men Taking Preexposure Prophylaxis (PrEP): Findings From the Expanded PrEP Implementation in Communities-New South Wales Prospective Implementation StudyJanaki Amin, Stefanie Vaccher, David J Templeton, et al.
Open Forum Infectious Diseases|December 18, 2024
Control and Elimination of Hepatitis C Virus Among People With HIV in Australia: Extended Follow-up of the CEASE Cohort (2014-2023)Marianne Martinello, Joanne M Carson, Jeffrey J Post, et al.
Viruses|November 11, 2022
Awareness of HCV Status and Preferences for Testing and Treatment among People with Recent Injecting Drug Use at a Peer-Led Needle and Syringe Program: The TEMPO Pilot StudyAnna Conway, Phillip Read, Rosie Gilliver, et al.
Sexual Health|August 12, 2014
High rates of sexually transmissible infections in HIV-positive patients in the Australian HIV Observational Database: a prospective cohort studyBrian P Mulhall, Stephen Wright, Debbie Allen, et al.
AIDS (London, England)|June 27, 2020
Low hepatitis C virus reinfection rate despite ongoing risk following universal access to direct-acting antiviral therapy among people living with HIVSamira Hosseini-Hooshyar, Marianne Martinello, Jasmine Yee, et al.
Vaccine|December 2, 2025
Drivers, barriers, and implications of mpox vaccine uptake in Australia among gay, bisexual, and other men who have sex with men: results from a prospective observational mixed-methods study (2022-2024)Mo Hammoud, Anthony K J Smith, Oskar Sachs, et al.
Eclinicalmedicine|April 18, 2024
Sex and gender differences in hepatitis C virus risk, prevention, and cascade of care in people who inject drugs: systematic review and meta-analysisAnna Levinsson, Camille Zolopa, Farzaneh Vakili, et al.
BMC Infectious Diseases|April 25, 2014
Rationale and design of REACT: a randomised controlled trial assessing the effectiveness of home-collection to increase chlamydia retesting and detect repeat positive testsKirsty S Smith, Jane S Hocking, Marcus Chen, et al.
BMC Infectious Diseases|January 29, 2024
Testing, diagnosis, and treatment following the implementation of a program to provide dried blood spot testing for HIV and hepatitis C infections: the NSW DBS PilotNigel Carrington, Anna Conway, Jason Grebely, et al.
Pageof 9

Showing results (51-60 of 82) with videos related to

Sort By:
Pageof 9
The International Journal on Drug Policy|August 24, 2021
Effectiveness of treatment for hepatitis C virus reinfection following direct acting antiviral therapy in the REACH-C cohortJoanne M Carson, Behzad Hajarizadeh, Josh Hanson, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 30, 2022
Low Prior Exposure and Incidence of Hepatitis C in Human Immunodeficiency Virus-Negative Gay and Bisexual Men Taking Preexposure Prophylaxis (PrEP): Findings From the Expanded PrEP Implementation in Communities-New South Wales Prospective Implementation StudyJanaki Amin, Stefanie Vaccher, David J Templeton, et al.
Open Forum Infectious Diseases|December 18, 2024
Control and Elimination of Hepatitis C Virus Among People With HIV in Australia: Extended Follow-up of the CEASE Cohort (2014-2023)Marianne Martinello, Joanne M Carson, Jeffrey J Post, et al.
Viruses|November 11, 2022
Awareness of HCV Status and Preferences for Testing and Treatment among People with Recent Injecting Drug Use at a Peer-Led Needle and Syringe Program: The TEMPO Pilot StudyAnna Conway, Phillip Read, Rosie Gilliver, et al.
Sexual Health|August 12, 2014
High rates of sexually transmissible infections in HIV-positive patients in the Australian HIV Observational Database: a prospective cohort studyBrian P Mulhall, Stephen Wright, Debbie Allen, et al.
AIDS (London, England)|June 27, 2020
Low hepatitis C virus reinfection rate despite ongoing risk following universal access to direct-acting antiviral therapy among people living with HIVSamira Hosseini-Hooshyar, Marianne Martinello, Jasmine Yee, et al.
Vaccine|December 2, 2025
Drivers, barriers, and implications of mpox vaccine uptake in Australia among gay, bisexual, and other men who have sex with men: results from a prospective observational mixed-methods study (2022-2024)Mo Hammoud, Anthony K J Smith, Oskar Sachs, et al.
Eclinicalmedicine|April 18, 2024
Sex and gender differences in hepatitis C virus risk, prevention, and cascade of care in people who inject drugs: systematic review and meta-analysisAnna Levinsson, Camille Zolopa, Farzaneh Vakili, et al.
BMC Infectious Diseases|April 25, 2014
Rationale and design of REACT: a randomised controlled trial assessing the effectiveness of home-collection to increase chlamydia retesting and detect repeat positive testsKirsty S Smith, Jane S Hocking, Marcus Chen, et al.
BMC Infectious Diseases|January 29, 2024
Testing, diagnosis, and treatment following the implementation of a program to provide dried blood spot testing for HIV and hepatitis C infections: the NSW DBS PilotNigel Carrington, Anna Conway, Jason Grebely, et al.
Pageof 9